BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23803696)

  • 21. Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma.
    Berndt SI; Huang WY; Fallin MD; Helzlsouer KJ; Platz EA; Weissfeld JL; Church TR; Welch R; Chanock SJ; Hayes RB
    Cancer Res; 2007 Feb; 67(3):1395-404. PubMed ID: 17283177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer.
    Gilsing AM; Berndt SI; Ruder EH; Graubard BI; Ferrucci LM; Burdett L; Weissfeld JL; Cross AJ; Sinha R
    Carcinogenesis; 2012 Jul; 33(7):1332-9. PubMed ID: 22552404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia.
    Wang H; Yamamoto JF; Caberto C; Saltzman B; Decker R; Vogt TM; Yokochi L; Chanock S; Wilkens LR; Le Marchand L
    Carcinogenesis; 2011 Feb; 32(2):203-9. PubMed ID: 21081473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.
    Han SS; Sue LY; Berndt SI; Selhub J; Burdette LA; Rosenberg PS; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):417-27. PubMed ID: 22253295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer.
    Li S; Zhao X; Wu Z; Li Y; Zhu L; Cui B; Dong X; Tian S; Hu F; Zhao Y
    Fam Cancer; 2013 Dec; 12(4):755-65. PubMed ID: 23715757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer.
    Liu L; Zhong R; Wei S; Yin JY; Xiang H; Zou L; Chen W; Chen JG; Zheng XW; Huang LJ; Zhu BB; Chen Q; Duan SY; Rui R; Yang BF; Sun JW; Xie DS; Xu YH; Miao XP; Nie SF
    PLoS One; 2011; 6(11):e27301. PubMed ID: 22087284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
    Barry EL; Poole EM; Baron JA; Makar KW; Mott LA; Sandler RS; Ahnen DJ; Bresalier RS; McKeown-Eyssen GE; Ulrich CM
    Cancer Causes Control; 2013 Jan; 24(1):47-54. PubMed ID: 23081681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study.
    Skjelbred CF; Saebø M; Wallin H; Nexø BA; Hagen PC; Lothe IM; Aase S; Johnson E; Hansteen IL; Vogel U; Kure EH
    BMC Cancer; 2006 Mar; 6():67. PubMed ID: 16542436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
    Mhatre S; Wang Z; Nagrani R; Badwe R; Chiplunkar S; Mittal B; Yadav S; Zhang H; Chung CC; Patil P; Chanock S; Dikshit R; Chatterjee N; Rajaraman P
    Lancet Oncol; 2017 Apr; 18(4):535-544. PubMed ID: 28274756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis.
    Jacobs ET; Hibler EA; Lance P; Sardo CL; Jurutka PW
    Int J Cancer; 2013 Dec; 133(12):2980-8. PubMed ID: 23754630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-[beta]1 -509T reduces risk of colorectal cancer, but not adenoma in Koreans.
    Chung SJ; Kim JS; Jung HC; Song IS
    Cancer Sci; 2007 Mar; 98(3):401-4. PubMed ID: 17214746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolites of tobacco smoking and colorectal cancer risk.
    Cross AJ; Boca S; Freedman ND; Caporaso NE; Huang WY; Sinha R; Sampson JN; Moore SC
    Carcinogenesis; 2014 Jul; 35(7):1516-22. PubMed ID: 24648381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
    Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.
    Garcia-Albeniz X; Nan H; Valeri L; Morikawa T; Kuchiba A; Phipps AI; Hutter CM; Peters U; Newcomb PA; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Carcinogenesis; 2013 Feb; 34(2):292-8. PubMed ID: 23104301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in inflammation pathway genes and endometrial cancer risk.
    Delahanty RJ; Xiang YB; Spurdle A; Beeghly-Fadiel A; Long J; Thompson D; Tomlinson I; Yu H; Lambrechts D; Dörk T; Goodman MT; Zheng Y; Salvesen HB; Bao PP; Amant F; Beckmann MW; Coenegrachts L; Coosemans A; Dubrowinskaja N; Dunning A; Runnebaum IB; Easton D; Ekici AB; Fasching PA; Halle MK; Hein A; Howarth K; Gorman M; Kaydarova D; Krakstad C; Lose F; Lu L; Lurie G; O'Mara T; Matsuno RK; Pharoah P; Risch H; Corssen M; Trovik J; Turmanov N; Wen W; Lu W; Cai Q; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):216-23. PubMed ID: 23221126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary 1-methylhistidine and 3-methylhistidine, meat intake, and colorectal adenoma risk.
    Cross AJ; Major JM; Rothman N; Sinha R
    Eur J Cancer Prev; 2014 Sep; 23(5):385-90. PubMed ID: 24681531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium.
    Kim HS; Newcomb PA; Ulrich CM; Keener CL; Bigler J; Farin FM; Bostick RM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):869-74. PubMed ID: 11489753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia is associated with an increased risk of advanced colorectal neoplasia.
    Park YS; Kim JW; Kim BG; Lee KL; Lee JK; Kim JS; Koh SJ
    Int J Colorectal Dis; 2017 Apr; 32(4):557-565. PubMed ID: 28013337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis.
    Kocarnik JD; Hutter CM; Slattery ML; Berndt SI; Hsu L; Duggan DJ; Muehling J; Caan BJ; Beresford SA; Rajkovic A; Sarto GE; Marshall JR; Hammad N; Wallace RB; Makar KW; Prentice RL; Potter JD; Hayes RB; Peters U
    Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3131-9. PubMed ID: 20978172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
    Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.